GGrantIndex
← Leaderboards

Alok Kapoor

Boston Medical Center

$4,011,183
Attributed
$5,717,058
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.2M · FY201125
$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,217,900 · 4
AHRQ$1,499,158 · 1

By mechanism

R01$3,411,751 · 1
R18$1,499,158 · 1
R21$472,162 · 1
R03$333,987 · 2

Top collaborators

Most similar at Boston Medical Center

Same institution · by research overlap

Others in their field

Top investigators on “American

Research focus

AmericanGuidelinesHemorrhageUniversitiesProviderReportingFuturePharmaceutical PreparationsCaringStrokeAdherenceRisk FactorsOralLearningHealth SystemAnticoagulationHeart RhythmAtrial FibrillationStroke RiskMeasurementPrevalenceEventDisabilityFalls

Grant awards (16)

SUPPORT-AF IV$419,713
R01 · FY2025 · HL · contact PI
SUPPORT-AF IV$225,422
R01 · FY2025 · HL · contact PI
SUPPORT-AF IV$617,957
R01 · FY2024 · HL · contact PI
Storytelling for Reducing Gap in AC Use in African Americans with Atrial Fibrillation$248,434
R21 · FY2024 · MD · contact PI
Association of Health Belief Variables, Religiosity, and Spirituality with AC Use in Older Adults with Atrial Fibrillation$226,261
R01 · FY2024 · HL · contact PI
SUPPORT-AF IV$633,918
R01 · FY2023 · HL · contact PI
Storytelling for Reducing Gap in AC Use in African Americans with Atrial Fibrillation$223,728
R21 · FY2023 · MD · contact PI
SUPPORT-AF IV$632,662
R01 · FY2022 · HL · contact PI
SUPPORT-AF IV$655,818
R01 · FY2021 · HL · contact PI
Leveraging Evidence-based practices for Ambulatory VTE Patients to be Safe with Direct Oral Anticoagulants: LEAVE Safe with DOACs$499,999
R18 · FY2021 · HS · contact PI
Leveraging Evidence-based practices for Ambulatory VTE Patients to be Safe with Direct Oral Anticoagulants: LEAVE Safe with DOACs$499,160
R18 · FY2020 · HS · contact PI
Leveraging Evidence-based practices for Ambulatory VTE Patients to be Safe with Direct Oral Anticoagulants: LEAVE Safe with DOACs$499,999
R18 · FY2019 · HS · contact PI
Older Adult Safety in Surgery (OASIS II)$81,237
R03 · FY2015 · AG · contact PI
Older Adult Safety in Surgery (OASIS II)$83,750
R03 · FY2014 · AG · contact PI
Older Adult Safety in Surgery (OASIS)$84,500
R03 · FY2012 · AG · contact PI
Older Adult Safety in Surgery (OASIS)$84,500
R03 · FY2011 · AG · contact PI